Arrowhead Pharmaceuticals Inc. (ARWR) Financial Statements (2025 and earlier)

Company Profile

Business Address 177 E COLORADO BLVD
PASADENA, CA 91105
State of Incorp. DE
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
MRQ
12/31/2024
MRQ
9/30/2024
9/30/2023
9/30/2022
9/30/2021
9/30/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments499,046578,276292,735268,391367,789315,492
Cash and cash equivalent     184,434143,583
Short-term investments499,046578,276292,735268,391183,355171,909
Restricted cash and investments2,1003,5007,9007,300  
Receivables2,500  1,41010,255846
Prepaid expense9,3669,5378,8137,2894,3624,251
Other current assets5,7354,9737,08220,2042,1911,782
Other undisclosed current assets51,78999,185102,991100,705  
Total current assets:570,536695,471419,521405,299384,597322,370
Noncurrent Assets
Operating lease, right-of-use asset44,86945,25545,29758,29117,34616,137
Property, plant and equipment387,069386,032290,262110,29748,67530,881
Long-term investments and receivables    105,872245,595137,487
Long-term investments    105,872245,595137,487
Intangible assets, net (including goodwill)8,1378,56210,26211,96213,66315,363
Intangible assets, net (excluding goodwill)8,1378,56210,26211,96213,66315,363
Other noncurrent assets3,0834,482210218272265
Total noncurrent assets:443,158444,331346,031286,640325,551200,133
TOTAL ASSETS:1,013,6941,139,802765,552691,939710,148522,504
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities73,85874,40575,62961,97533,23120,278
Employee-related liabilities12,2519,7738,061
Accounts payable14,45711,38835,8662,8689,4576,829
Accrued liabilities59,40163,01739,76346,85614,0015,389
Deferred revenue  86674,099111,05519,291
Debt1,625     
Other liabilities440432435  17
Other undisclosed current liabilities17,83528,33128,5262,7762,2501,095
Total current liabilities:93,758103,168105,456138,850146,53640,681
Noncurrent Liabilities
Long-term debt and lease obligation407,789393,183 78,80023,29520,043
Long-term debt, excluding current maturities407,789393,183    
Liabilities, other than long-term debt109,296111,027104,60855,950131,495 
Deferred revenue    55,950131,495 
Operating lease, liability109,296111,027104,60878,80023,29520,043
Other undisclosed noncurrent liabilities346,776341,361268,326  (20,043)
Total noncurrent liabilities:863,861845,571372,934134,750154,79020,043
Total liabilities:957,619948,739478,390273,600301,32660,725
Equity
Equity, attributable to parent52,589185,444271,343398,520408,822461,779
Common stock218217200198197195
Additional paid in capital1,846,8421,806,0001,300,3951,219,2131,053,386965,410
Accumulated other comprehensive income (loss)4,1374,750(3,222)(136)(69)18
Accumulated deficit(1,798,608)(1,625,523)(1,026,030)(820,755)(644,692)(503,844)
Equity, attributable to noncontrolling interest3,4865,61915,81919,819  
Total equity:56,075191,063287,162418,339408,822461,779
TOTAL LIABILITIES AND EQUITY:1,013,6941,139,802765,552691,939710,148522,504

Income Statement (P&L) ($ in thousands)

3/31/2025
TTM
12/31/2024
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Revenues2,5003,551240,735243,231138,28787,992
Gross profit:2,5003,551240,735243,231138,28787,992
Operating expenses(628,447)(604,631)(445,737)(421,738)(287,323)(181,151)
Operating loss:(625,947)(601,080)(205,002)(178,507)(149,036)(93,159)
Nonoperating income (expense)(22,939)(11,380)(1,489)5,7988,1908,608
Investment income, nonoperating27,52022,72015,299   
Other nonoperating income (expense)(1,828)(1,748)1,5387652,070(583)
Interest and debt expense(48,631)(32,352)(18,326)   
Loss from continuing operations before equity method investments, income taxes:(697,517)(644,812)(224,817)(172,709)(140,846)(84,551)
Other undisclosed income from continuing operations before income taxes48,63132,35218,326   
Loss from continuing operations before income taxes:(648,886)(612,460)(206,491)(172,709)(140,846)(84,551)
Income tax expense (benefit)(649)2,767(2,784)(3,785)(2)(2)
Loss from continuing operations:(649,535)(609,693)(209,275)(176,494)(140,848)(84,553)
Loss before gain (loss) on sale of properties:(176,494)(140,848)(84,553)
Net loss:(649,535)(609,693)(209,275)(176,494)(140,848)(84,553)
Net income attributable to noncontrolling interest9,82110,2004,000431  
Net loss available to common stockholders, diluted:(639,714)(599,493)(205,275)(176,063)(140,848)(84,553)

Comprehensive Income ($ in thousands)

3/31/2025
TTM
12/31/2024
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Net loss:(649,535)(609,693)(209,275)(176,494)(140,848)(84,553)
Other undisclosed comprehensive income (loss)5,3927,972(3,086)(67)  
Comprehensive loss:(644,143)(601,721)(212,361)(176,561)(140,848)(84,553)
Comprehensive income, net of tax, attributable to noncontrolling interest9,82110,2004,000431  
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     (87)410
Comprehensive loss, net of tax, attributable to parent:(634,322)(591,521)(208,361)(176,130)(140,935)(84,143)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: